EBNEO Commentary: De-MIST-ifying the 2-year outcomes of non-invasive surfactant therapy

Acta Paediatr. 2024 May;113(5):1121-1122. doi: 10.1111/apa.17116. Epub 2024 Jan 25.

Authors

Lucy Loft¹, Kristin N Ferguson^{2

3}, David G Tingay^{2

4}

Affiliations

¹ Neonatology, The Royal Women's Hospital, Melbourne, Victoria, Australia.
² Neonatal Research, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
³ Neonatology, Mercy Hospital for Women, Melbourne, Victoria, Australia.
⁴ Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.

PMID: 38269640
DOI: 10.1111/apa.17116

No abstract available

Keywords: brochopulmonary dysplasia; preterm; respiratory function; surfactant.

MeSH terms

Bronchopulmonary Dysplasia*
Continuous Positive Airway Pressure
Humans
Infant, Newborn
Infant, Premature
Pulmonary Surfactants* / therapeutic use
Respiratory Distress Syndrome, Newborn* / therapy
Surface-Active Agents / therapeutic use

Substances

Surface-Active Agents
Pulmonary Surfactants

Grants and funding